IntriCon Receives 510(k) Clearance for Diagnostic Monitor

IntriCon has received 510(k) clearance from the FDA for its Centauri cardiac diagnostic monitor. The device combines event recording with wireless transmission of patient data, allowing physicians to continuously monitor patient cardiac events remotely.